Cellular and debris membranes

Cellular and debris membranes refer to the phospholipid bilayers of living cells and the fragmented remnants of cells that have undergone necrosis or apoptosis (1). In a pharmacological context, these structures are generally considered substrates for therapeutic intervention rather than specific molecular targets like receptors or enzymes. For instance, lipopeptide antibiotics like daptomycin target the integrity of bacterial inner membranes to cause rapid depolarization and cell death (2). In chronic respiratory conditions such as cystic fibrosis, the accumulation of cellular debris—specifically DNA from neutrophils—increases mucus viscosity, which is therapeutically addressed by dornase alfa to cleave the DNA and facilitate clearance (3). Furthermore, the failure of the body to efficiently clear cellular debris (a process known as efferocytosis) is a significant driver of inflammation and autoimmunity, as the persistence of these membranes leads to the release of damage-associated molecular patterns (DAMPs) that trigger immune activation (4). Consequently, while 'cellular and debris membranes' is too broad to be a canonical drug target, it represents a critical physical site for antimicrobial action, wound debridement, and the management of inflammatory exudates.

Other names

Cell membranesBiological membranesNecrotic debrisCellular debrisApoptotic debris

Membrane disruption, enzymatic degradation of debris components (e.g., DNA), and physical surfactant action to reduce surface tension or viscosity.